$CAPR Ok, based on the interview posted below, we're more likely to have an update on their exosomes program with US Army for trauma patients before anything else! Also, it appears that as of date of this interview, FDA still had not approved their amended protocol for 40 patients. So, we're more likely to get updates on Vaccine program & exosomes program with US Army before any update on CAP-1002 for Covid-19 severe patients.
@PTInvestments fellas - I believe the fda approved the expanded 20 patients on May 27th. The gov trials site clearly reflects this. I think she is waiting for grant money or other non dilutive sources.